EUTECNIQAtlas

Every page of EUTECNIQ on one mapArrow keys move through results · Enter opens · Esc closes

Supplements A–Z Botanical Sources: 4

Hawthorn Crataegus monogyna Jacq. and Crataegus laevigata (Poir.) DC.

Also called: Crataegus, hawthorn leaf and flower, hawthorn berry

A group of thorny shrubs and trees (Crataegus species). Products use the leaf and flower, and sometimes the fruit, and have been studied mainly in people with chronic heart failure.

Category
Botanical
Part used
Leaf and flower; fruit
Strongest evidence
B Some positive trials
Reviewed
2026-10-28

Class 1 Well studied in people. A 2008 Cochrane review included 14 double-blind RCTs of hawthorn leaf-and-flower extract monopreparations versus placebo for chronic heart failure, mostly added to usual treatment; 10 trials (855 patients) gave data suitable for meta-analysis. [3]

Fact-checked 2026-10-28 · How this guide is made

Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.

Evidence

What research has studied

Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.

4 topics studied3 body areas · strongest grade B

A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials

From the table below Each topic in the table is placed on the part of the body it names, colored by its strongest grade. Tap an area, or open a line in the list, to see its topics. The map shows what was studied, not what Hawthorn does: a C or X area is not evidence of benefit. All 1,071 findings on one body map.
Topics studied for Hawthorn, evidence grade and finding
Topic studiedGradeWhat the evidence shows
Symptoms and exercise capacity in chronic heart failure (NYHA I–III), added to usual careBCochrane meta-analysis of 10 trials (855 patients): maximal workload rose 5.35 W versus placebo, and shortness of breath and fatigue improved; no relevant mortality or morbidity data were reported, apart from one trial that reported deaths (three hawthorn, one placebo) without further detail. [3]
Heart failure outcomes in later researchCNCCIH describes the evidence on heart failure as conflicting; one study of a specific preparation suggested a possible early risk of heart failure progression. [1]
Heart disease, angina, abnormal heartbeat, plaque buildupCNCCIH states there is not enough evidence to know whether hawthorn helps these conditions. [1]
AnxietyCNCCIH states it is unclear whether hawthorn affects anxiety. [1]

Main constituents: Flavonoids and oligomeric procyanidins are credited with the pharmacologic activity [2]

Safety

Safety and side effects

  • Liver (NIH LiverTox)
    Score E
    A: well known causeE: unlikely cause

    LiverTox likelihood score E (unlikely cause of clinically apparent liver injury), chapter last updated January 28, 2023.

    Details and sources
  • Pregnancy and breastfeeding
    MSK: traditional medicine cautions include avoiding hawthorn during pregnancy.

    2 statements in the profile.

    Details and sources
  • Interactions with medicines
    5 listed

    Digoxin; Heart failure medicines; Anticoagulants and antiplatelet drugs; Drugs metabolized by CYP3A4 …

    Details and sources
  • Cancer evaluations (IARC, NTP)
    None found

    No IARC or NTP evaluation was found in the lists checked.

    Details and sources
  • FDA new dietary ingredient notifications
    7 on FDA's list

    FDA does not approve dietary supplements. Each entry is one party's filing.

    Details and sources
  • Dose in official monographs
    Stated

    Health Canada (monograph dated July 31, 2026), adults 18 and older: dried flower and leaf 1.5-5 g per day …

    Details and sources
  • Some hawthorn supplements might be safe short-term; no studies have tested use beyond 16 weeks. Side effects include dizziness, nausea, vomiting, diarrhea and muscle pain. [1]
  • In heart failure trials, adverse events were infrequent, mild and transient (nausea, dizziness, cardiac and gastrointestinal discomfort). [3]
  • Overdose effects listed: low blood pressure and irregular heartbeat. Hawthorn should not be used in place of proven conventional therapies for heart failure. [2]
  • FDA has warned about several hawthorn root dietary supplements: in January 2024 it reported that some products labeled 'tejocote root' (Mexican hawthorn, C. mexicana) actually contain yellow oleander, a toxic plant, and may cause severe harm or even be fatal. [1]
  • Pregnancy and breastfeeding: NCCIH says little is known about safety [1]; traditional cautions include avoiding hawthorn during pregnancy. [2]
Interactions

Interactions

Hawthorn
From the table below 4 interactions the sources name. Tap one to read what happens. A line means a documented or possible interaction, not its size.
Known interactions of Hawthorn
WithWhat happens
DigoxinLab data suggest hawthorn alkaloids are structurally similar to digoxin and may interfere with its action; use only under the treating physician's guidance. [2]
Heart failure medicinesPatients taking heart failure medications should use hawthorn only under direction and monitoring by their physician. [2]
Anticoagulants and antiplatelet drugsA lab study suggests hawthorn flowers may inhibit thromboxane A2 synthesis; avoid unless closely monitored. Clinical relevance is not determined. [2]
Drugs metabolized by CYP3A4Lab studies suggest hawthorn may affect their metabolism; clinical relevance has yet to be determined. [2]

Tell a pharmacist or doctor about every supplement you take. All documented interactions in this hub.

Quality

Identity, quality and standardization

  • Some products labeled 'tejocote root' were found to contain yellow oleander instead (FDA, January 2024). [1]
Regulation

Regulatory status

  • US: sold as a dietary supplement ingredient; supplements are not FDA-approved before sale. [1]
  • EU: hawthorn leaf and flower has a European Union herbal monograph based on traditional use for temporary nervous heart complaints such as palpitations, after a doctor has excluded serious conditions (adults), and for mild mental stress and to aid sleep (over 12). [4]
Profile

Safety, quality and supply profile

Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.

Compounds responsible

Compounds the sources name as the main or characteristic actives.

  • Flavonoids and oligomeric procyanidins (credited with the pharmacologic activity) Flavonoids; oligomeric procyanidins [P1]
  • Extracts of berries and leaves also contain phenylpropanoids, lignans, triterpenoids and glycosides Phenylpropanoids; lignans; triterpenoids; glycosides [P2]

US status

What FDA's published records show. FDA does not approve dietary supplements.

  • FDA's published NDI notification list has 7 entries naming hawthorn or a Crataegus species (earliest NDI 197 submitted 2003-01-22; most recent NDI 550 submitted 2008-07-17). Each entry is one party's notification; the list gives the date of FDA's response letter but not what it said. [P3]
  • FDA warned in January 2024 that some products labeled 'tejocote root' (Mexican hawthorn, Crataegus mexicana) actually contained yellow oleander, a toxic plant, and may cause severe harm or even be fatal. [P4]

Cancer evaluations (IARC and NTP)

Evaluations name the exact material tested, which may differ from a supplement.

  • No IARC or NTP carcinogenicity evaluation of hawthorn (Crataegus) was found (IARC Monographs list of classifications and NTP technical reports checked 2026-10-29). [P5]
  • NTP technical reports list checked 2026-10-29: no report on hawthorn. [P6]

Liver (NIH LiverTox)

  • LiverTox likelihood score E (unlikely cause of clinically apparent liver injury), chapter last updated January 28, 2023. [P2]

Interactions with medicines

  • Digoxin: Lab data suggest hawthorn alkaloids are structurally similar to digoxin and may interfere with its action; use only under the treating physician's guidance. [P1]
  • Heart failure medicines: Patients taking heart failure medications should use hawthorn only under direction and monitoring by their physician. [P1]
  • Anticoagulants and antiplatelet drugs: A lab study suggests hawthorn flowers may inhibit thromboxane A2 synthesis; clinical relevance is not determined. [P1]
  • Drugs metabolized by CYP3A4: Lab studies suggest hawthorn may affect their metabolism; clinical relevance has yet to be determined. [P1]
  • Cardiac glycosides, blood pressure or heart medications: Health Canada's monograph requires a caution to ask a health care practitioner before use if taking cardiac glycosides (e.g., digoxin) or blood pressure or heart medications. [P8]

Alcohol

  • No published information found in the sources checked.

Interactions with other herbs and supplements

  • No published information found in the sources checked.

Adulteration and substitution

  • FDA (January 2024): some products labeled 'tejocote root' (Mexican hawthorn) were found to contain yellow oleander instead. [P4]

What a certificate of analysis should cover

Tests a quality specification for this material would include, with the reason for each.

  • Identity test or examination of each dietary-ingredient component — 21 CFR 111.75(a)(1)(i) requires at least one appropriate test or examination to verify the identity of any component that is a dietary ingredient, unless FDA grants an exemption petition under 111.75(a)(1)(ii). [P7]
  • Species and plant-part identity (excluding toxic substitutes) — Products labeled 'tejocote root' (Crataegus mexicana) were found to contain yellow oleander (FDA, January 2024). [P4]
  • Marker assay for standardized extracts: oligomeric procyanidins (as epicatechin) and/or flavonoids (as hyperoside) — Health Canada's monograph defines standardized flower-and-leaf extracts at 18.75% oligomeric procyanidins as epicatechin and/or 2.2% flavonoids as hyperoside. [P8]

Supply and conservation

  • Crataegus monogyna, IUCN Red List: Least Concern (LC), via GBIF species API, retrieved 2026-10-29. [P9]
  • Crataegus laevigata, IUCN Red List: Least Concern (LC), via GBIF species API, retrieved 2026-10-29. [P10]

Absorption in people

  • No published information found in the sources checked.

Formulations studied to change absorption

Human data only.

  • No published information found in the sources checked.

Dose in official monographs

As the monograph states it, for its jurisdiction; not personal advice.

  • Health Canada (monograph dated July 31, 2026), adults 18 and older: dried flower and leaf 1.5-5 g per day; standardized ethanolic dry extract of flower and leaf 160-900 mg per day; dried fruit 0.6-3.5 g per day (ethanolic or powdered preparations) or 1.5-6 g per day (aqueous preparations). [P8]

Pregnancy and breastfeeding

  • MSK: traditional medicine cautions include avoiding hawthorn during pregnancy. [P1]
  • NCCIH: little is known about whether it is safe to use hawthorn during pregnancy or while breastfeeding. [P4]

Sources for this profile

  1. Memorial Sloan Kettering Cancer Center. About Herbs: Hawthorn (last updated June 3, 2022), 2022-06-03. mskcc.org
  2. NIH LiverTox. Hawthorn (last update January 28, 2023), 2023-01-28. ncbi.nlm.nih.gov
  3. FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
  4. NCCIH. Hawthorn: Usefulness and Safety (last updated April 2025), 2025-04. nccih.nih.gov
  5. IARC Monographs. List of Classifications: agents classified by the IARC Monographs, Volumes 1-142 (last updated 2026-07-23), 2026-07-23. monographs.iarc.who.int
  6. National Toxicology Program (NIEHS). Technical Reports list (checked 2026-10-29), 2026-10-29. ntp.niehs.nih.gov
  7. eCFR. 21 CFR 111.75 What must you do to determine whether specifications are met? (up to date as of 10/23/2026), 2026-10-23. ecfr.gov
  8. Health Canada, NNHPD. Monograph: Hawthorn (date 2026-07-31), 2026-07-31. webprod.hc-sc.gc.ca
  9. GBIF species API: IUCN Red List category for Crataegus monogyna Jacq., 2026-10-29. api.gbif.org
  10. GBIF species API: IUCN Red List category for Crataegus laevigata (Poir.) DC., 2026-10-29. api.gbif.org
Sources

Sources

  1. NCCIH. Hawthorn: Usefulness and Safety (last updated April 2025), 2025-04. nccih.nih.gov
  2. Memorial Sloan Kettering Cancer Center. About Herbs: Hawthorn (last updated June 3, 2022), 2022-06-03. mskcc.org
  3. Pittler MH, Guo R, Ernst E. Hawthorn extract for treating chronic heart failure. Cochrane Database of Systematic Reviews 2008;(1):CD005312 (PubMed abstract, PMID 18254076), 2008-01-23. pubmed.ncbi.nlm.nih.gov
  4. European Medicines Agency. Crataegi folium cum flore: herbal medicinal product (monograph 17/06/2016; draft Rev. 1 15/04/2025), 2025-04-15. ema.europa.eu
A
Consistent results from several randomized trials or a systematic review of them
B
Some positive randomized trials, but small, short, few or inconsistent
C
Limited human evidence: single small trials, observational data or mixed results
D
Laboratory or animal evidence only; not shown in people
X
Well-designed human trials found no meaningful effect

More in botanical: Aloe vera · American ginseng · Amla · Andrographis · Arjuna · Arnica · Aronia (black chokeberry) · Asafoetida · All entries A–Z · How to judge a supplement

Health information notice

These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.

Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.

EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.

Ready to check what you take?

Free tools built on published reference values, each with its sources and its limits. Your lists stay in your browser.